BIOASCENT DISCOVERY LIMITED

Active Edinburgh

Research and experimental development on biotechnology

83 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
B

BIOASCENT DISCOVERY LIMITED

Research and experimental development on biotechnology

Founded 15 Feb 2013 Active Edinburgh, United Kingdom 83 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology

Previous Company Names

CALEDONIAN DRUG DISCOVERY LIMITED 15 Feb 2013 — 22 Apr 2013
Accounts Submitted 13 Oct 2025 Next due 30 Sept 2026 4 months remaining
Confirmation Submitted 24 Apr 2026 Next due 1 Mar 2022 52 months overdue
Net assets £6M £2M 2024 year on year
Total assets £9M £2M 2024 year on year
Total Liabilities £3M £247K 2024 year on year
Charges 2
1 outstanding 1 satisfied

Contact & Details

Contact

Registered Address

C/O Cms Cameron Mckenna Nabarro Olswang Llp Saltire Court 20 Castle Terrace Edinburgh EH1 2EN United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for BIOASCENT DISCOVERY LIMITED (SC442915), an active life sciences and medical technology company based in Edinburgh, United Kingdom. Incorporated 15 Feb 2013. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 4 months remaining

Balance Sheet & P&L (2013–2024)

Cash in Bank

£25.55k

Decreased by £268.65k (-91%)

Net Assets

£6.33M

Increased by £1.64M (+35%)

Total Liabilities

£2.77M

Increased by £246.54k (+10%)

Turnover

£9.53M

Decreased by £201.67k (-2%)

Employees

83

Increased by 3 (+4%)

Debt Ratio

30%

Decreased by 5 (-14%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2022
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 2

Investors (1)

Investor NameInvestor SinceParticipating Rounds
Investor 1Jun 2018Seed

Share Capital

Share Capital

Share allotments and capital structure

2 Allotments 178 Shares £2k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
9 Nov 2013175£2k£10
22 Apr 20133£3£1

Officers

Officers

1 active 2 resigned
Status
Nisbet, Louis Joseph, DrDirectorBritishEngland7820 Jun 2018Active

Shareholders

Shareholders (7)

Biocity Group Limited
50.0%
Maven Income And Growth Vct Plc
10.1%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

Biocity Group Limited

United Kingdom

Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

Biocity Scotland Limited

Ceased 20 Jun 2018

Ceased

Group Structure

Group Structure

BIOASCENT DISCOVERY LIMITED Current Company

Charges

Charges

1 outstanding 1 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
24 Apr 2026Confirmation StatementReplacement Filing Of Confirmation Statement With Made Up Date
24 Apr 2026Confirmation StatementReplacement Filing Of Confirmation Statement With Made Up Date
14 Apr 2026Confirmation StatementConfirmation statement made on 15 Feb 2026 with no updates
9 Feb 2026OfficersTermination of Paul Smith as director on 14 Jan 2026
13 Oct 2025AccountsAnnual accounts made up to 31 Dec 2024
24 Apr 2026 Confirmation Statement

Replacement Filing Of Confirmation Statement With Made Up Date

24 Apr 2026 Confirmation Statement

Replacement Filing Of Confirmation Statement With Made Up Date

14 Apr 2026 Confirmation Statement

Confirmation statement made on 15 Feb 2026 with no updates

9 Feb 2026 Officers

Termination of Paul Smith as director on 14 Jan 2026

13 Oct 2025 Accounts

Annual accounts made up to 31 Dec 2024

Recent Activity

Latest Activity

Replacement Filing Of Confirmation Statement With Made Up Date

1 months ago on 24 Apr 2026

Replacement Filing Of Confirmation Statement With Made Up Date

1 months ago on 24 Apr 2026

Confirmation statement made on 15 Feb 2026 with no updates

1 months ago on 14 Apr 2026

Termination of Paul Smith as director on 14 Jan 2026

3 months ago on 9 Feb 2026

Annual accounts made up to 31 Dec 2024

7 months ago on 13 Oct 2025